Skip to main content
. 2015 Nov 12;2(1):e000113. doi: 10.1136/lupus-2015-000113

Table 4.

Findings of the univariable analysis (UVA) and multivariable analysis (MVA)

Variable name Catastrophising
Coping
p Value (UVA) Correlation coefficient p Value (MVA) p Value (UVA) Correlation coefficient p Value (MVA)
SF-12 PCS <0.001 −0.250** NS
SF-12 MCS <0.001 −0.443** <0.001 0.001 0.171** NS
SLAQ score <0.001 0.475* 0.042 NS NS
VFS score <0.001 0.367* NS
SLICC/ACR DI <0.001 0.192* NS
Number of concomitant diseases <0.001 0.202* NS
Number of lupus-specific drugs <0.001 0.204* 0.004 NS NS
Inability to work 0.001 0.213* NS
Degree of disability (%) 0.003 0.169** NS
Pain in the last 7 days <0.001 0.420* 0.034 NS NS
Impairment in the last 7 days <0.001 0.388* NS
Disease flares during last 3 months <0.001 0.280* NS
Social participation NSX NS 0.001X 0.006

Data are p values and correlation coefficients. Correlations were carried out by Spearman's (*) and Pearson's (**) correlations. The p values for catastrophising and coping in the UVA were derived from Spearman's and Pearson's correlation or from the Mann–Whitney U test (x). The p values for catastrophising and coping in the MVA were derived from ANOVA (analysis of variance). Only complete cases (n=323) were included in the MVA.

SF-12 MCS, SF-12 Mental Component Summary; SF-12 PCS, SF-12 Physical Component Summary; SLAQ, Systemic Lupus Activity Questionnaire; SLICC/ACR DI, Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index; VFS, Vanderbilt Fatigue Score.